(1) DNAを用いたPCRやクローニング (2) 細胞培養や培養細胞を用いたプレートアッセイ (3) in situ hybridizationや免疫組織染色 (4) マウスを用いた病態モデルの解析
代表論文
*Jo-Watanabe A, Inaba T, Osada T, Hashimoto R, Nishizawa T, Okuno T, Ihara S, Touhara K, Hattori N, Oh-Hora M, Nureki O, *Yokomizo T: Bicarbonate signalling via G protein-coupled receptor regulates ischaemia-reperfusion injury. Nat Commun. 15(1):1530, 2024.
Shioda R, Jo-Watanabe A, Okuno T, Saeki K, Nakayama M, Suzuki Y, *Yokomizo T: The leukotriene B4 /BLT1-dependent neutrophil accumulation exacerbates immune complex-mediated glomerulonephritis. FASEB J. 37(2): e22789, 2023.
Shioda R, Jo-Watanabe A, Lee-Okada HC, Yasukawa K, Okuno T, Suzuki Y, *Yokomizo T: Dietary intake of n-3 polyunsaturated fatty acids alters the lipid mediator profile of the kidney but does not attenuate renal insufficiency. Biochem Biophys Res Commun. 582:49-56, 2021.
Uzawa H, Kohno D, Koga T, Sasaki T, Fukunaka A, Okuno T, Jo-Watanabe A, Kazuno S, Miyatsuka T, Kitamura T, Fujitani Y, Watada H, *Saeki K, Yokomizo T: Leukotriene A4 hydrolase deficiency protects mice from diet-induced obesity by increasing energy expenditure through neuroendocrine axis. FASEB J. 34(10): 13949-13958, 2020.
Jo-Watanabe A, Okuno T, *Yokomizo T: The Role of Leukotrienes as Potential Therapeutic Targets in Allergic Disorders. Int. J. Mol. Sci. 20(14): 3580, 2019.
Shigematsu M, Koga T, Ishimori A, Saeki K, Ishii Y, Taketomi Y, Ohba M, Jo-Watanabe A, Okuno T, Harada N, Harayama T, Shindou H, Li JD, Murakami M, Hoka S, *Yokomizo T: Leukotriene B4 receptor type 2 protects against pneumolysin-dependent acute lung injury. Sci Rep. 6: 34560, 2016.
Jo-Watanabe A, Ohse T, Nishimatsu H, Takahashi M, Ikeda Y, Wada T, Shirakawa J, Nagai R, Miyata T, Nagano T, Hirata Y, *Inagi R, *Nangaku M: Glyoxalase I reduces glycative and oxidative stress and prevents age-related endothelial dysfunction through modulation of endothelial nitric oxide synthase phosphorylation. Aging Cell. 13(3): 519-528, 2014.
Furuse SU, Ohse T, Jo-Watanabe A, Shigehisa A, Kawakami K, Matsuki T, Chonan O, *Nangaku M: Galacto-oligosaccharides attenuate renal injury with microbiota modification. Physiol Rep. 2(7): e12029, 2014.
Jo A, Ohse T, Nishimatsu H, Takahashi M, Ikeda Y, Miyata T, Hirata Y, Nangaku M, *Inagi R: Glyoxalase I regulates age-related glycative stress and prevents age-related endothelial dysfunction through modulation of eNOS phosphorylation. IMARS Highlights. 8: 19-20, 2013. [日本メイラード学会若手奨励賞受賞記念論文]
*Hirahashi J, Jo A, Ueda K, Tojo A, Fujita T: Successful treatment of ANCA-associated vasculitis with eicosapentaenoic acid. Ann Intern Med. 156(10): 755-756, 2012.
Jo A, Ishibashi Y, *Hirohama D, Takara Y, Kume H, Fujita T: Early surgical intervention may prevent peritonitis in cases with Tenckhoff catheter infection by nontuberculous mycobacterium. Perit Dial Int. 32(2): 227-229, 2012.
Amiya E, *Ishizaka N, Watanabe A, Endo Y, Itou R, Yoshida S, Nangaku M, Nagai R: Retroperitoneal fibrosis with periaortic and pericardial involvement. Circ J. 69(6): 760-762, 2005.
Watanabe A, Kato N, *Kato T: Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neurosci Res. 42(4): 279-285, 2002.